N
VIVO

Nuveen’s Meridian Bioscience Inc VIVO Stock Holding History

Nuveen’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-329,146
Closed -$10.9M – 3179
2022
Q4 		$10.9M Sell
329,146
-103,682
-24% -$3.34M ﹤0.01% 1430
2022
Q3 		$13.6M Buy
432,828
+3,788
+0.9% +$123K 0.01% 1284
2022
Q2 		$13.1M Buy
429,040
+180,951
+73% +$4.89M 0.01% 1341
2022
Q1 		$6.24M Sell
248,089
-135,569
-35% -$3.22M ﹤0.01% 1942
2021
Q4 		$7.83M Sell
383,658
-184,311
-32% -$3.53M ﹤0.01% 1834
2021
Q3 		$10.9M Sell
567,969
-112,002
-16% -$2.23M ﹤0.01% 1715
2021
Q2 		$15.1M Buy
679,971
+48,778
+8% +$1.03M ﹤0.01% 1587
2021
Q1 		$16.6M Sell
631,193
-9,134
-1% -$217K 0.01% 1460
2020
Q4 		$12M Sell
640,327
-196,954
-24% -$3.68M ﹤0.01% 1587
2020
Q3 		$14.2M Sell
837,281
-129,507
-13% -$2.52M 0.01% 1271
2020
Q2 		$22.5M Buy
966,788
+201,885
+26% +$2.93M 0.01% 965
2020
Q1 		$6.42M Buy
764,903
+244,478
+47% +$2.06M ﹤0.01% 1565
2019
Q4 		$5.08M Buy
520,425
+81,916
+19% +$769K ﹤0.01% 1987
2019
Q3 		$4.16M Buy
438,509
+164,828
+60% +$1.74M ﹤0.01% 2054
2019
Q2 		$3.25M Buy
+273,681
New +$3.3M ﹤0.01% 2212

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Nuveen's VIVO Position: Q1 2023 in Review

Nuveen sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 329,146 shares — an estimated $10.9M sold.

Nuveen first reported a position in VIVO in Q2 2019 and held it in 15 quarters. The position peaked at $22.5M in Q2 2020. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • Nuveen reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • Nuveen sold 329,146 Meridian Bioscience Inc shares in Q1 2023, an estimated $10.9M.
  • Nuveen first reported a position in Meridian Bioscience Inc in Q2 2019 and held it in 15 quarters.
  • Nuveen's Meridian Bioscience Inc position peaked at $22.5M in Q2 2020.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Nuveen's 13F filing for Q1 2023, filed 15 May 2023.